Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum
Clinical trial NCT01313429 · TERMINATED
Trial details
- NCT number
- NCT01313429
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-04
- Primary completion
- 2020-02-26
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.